Highbridge Capital Management’s Dermira, Inc. DERM Stock Holding History

Highbridge Capital Management’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-50,000	Closed	-$678K	–	350
2019 Q1	$678K	Sell	50,000 -239,700	-83%	-$2M	0.02%	293
2018 Q4	$2.08M	Buy	+289,700	New	+$3.17M	0.06%	224

Other funds holding DERM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Highbridge Capital Management's DERM Position: Q2 2017 in Review

Highbridge Capital Management sold out of Dermira, Inc. (DERM) in Q2 2017, closing a stake of 37,785 shares — an estimated $1.29M sold.

Highbridge Capital Management first reported a position in DERM in Q4 2015 and held it in 3 quarters. The position peaked at $1.29M in Q1 2017. 121 funds tracked by Wall St. Rank hold DERM as of Q2 2017.

Highbridge Capital Management reported no remaining Dermira, Inc. position as of Q2 2017 after selling out during the quarter.
Highbridge Capital Management sold 37,785 Dermira, Inc. shares in Q2 2017, an estimated $1.29M.
Highbridge Capital Management first reported a position in Dermira, Inc. in Q4 2015 and held it in 3 quarters.
Highbridge Capital Management's Dermira, Inc. position peaked at $1.29M in Q1 2017.
121 funds tracked by Wall St. Rank held Dermira, Inc. as of Q2 2017.

Based on Highbridge Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.